- Featured Product
- KD/KO Validated
CHD9 Polyklonaler Antikörper
CHD9 Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 13402-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
13402-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA CHD9 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | CHD9 fusion protein Ag4245 |
| Vollständiger Name | chromodomain helicase DNA binding protein 9 |
| Berechnetes Molekulargewicht | 2897 aa, 326 kDa |
| Beobachtetes Molekulargewicht | 330 kDa |
| GenBank-Zugangsnummer | BC033770 |
| Gene symbol | CHD9 |
| Gene ID (NCBI) | 80205 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CHD (chromodomain helicase DNA-binding) proteins are chromatin remodelling enzymes which reshape the local chromatin architecture to allow access to transcriptional machinery in a tissue-specific context. CHD proteins facilitate various stages of gene expression, including binding and recruiting transcription factors, histone modifications, and transcriptional elongation, termination and processing. CHD proteins are characterized by two tandem chromodomains and a helicase C domain, but also possesses additional functional domains which classify them into three subfamilies. CHD9 is active in mesenchymal stromal stem cells and osteoprogenitor cells, and is suggested to control osteogenic cell fate (PMID: 32295522).









